Physician profile
Roberta E Funck
NPI 1700086816
$1,416.06
in general payments reported to CMS, 2019-2025
19 companies · $277 in 2025
The $277 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $282 · 2022: $251 · 2023: $246 · 2024: $360 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $883.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $306.09 | 2021-2024 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Amgen INC. | $194.77 | 2021-2024 | Prolia, Evenity, Tepezza |
| Insulet Corporation | $120.27 | 2021-2024 | Omnipod |
| Novo Nordisk INC | $102.99 | 2022-2025 | Wegovy, Ozempic |
| Sequel Med Tech, LLC | $102.89 | 2025 | Twiist |
| Sanofi-Aventis U.S. LLC | $102.57 | 2021-2023 | |
| Dexcom, INC. | $88.85 | 2024 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $70.76 | 2021-2022 | |
| Horizon Therapeutics Plc | $55.93 | 2023 | Tepezza |
| Abbott Laboratories | $49.45 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Abbvie INC. | $46.14 | 2022 | |
| Ascendis Pharma Endocrinology INC | $44.12 | 2025 | Yorvipath |
| Mannkind Corporation | $39.48 | 2024 | |
| Radius Health, INC. | $19.62 | 2025 | Tymlos |
| Tandem Diabetes Care, INC. | $18.04 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $15.59 | 2023 | Rytary |
| Cequr Corporation | $14.99 | 2025 | Cequr Simplicity |
| Alvogen INC | $13.66 | 2025 | Teriparatide |
| Beta Bionics, INC. | $9.85 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberta Funck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.